Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000119 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 3, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
86,799
Total Value
$3,053,430.05
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and Corporate Secretary | Common Stock | โ | Oct 1, 2026 | Exercise/Conversion | 28,933 | $14.50 | $419,528.50 | 31,778 | Direct | โ | View Details | |
Chief Legal Officer and Corporate Secretary | Common Stock | โ | Oct 1, 2026 | Sale | 400 | $89.24 | $35,696.00 | 31,378 | Direct | โ | View Details | |
Chief Legal Officer and Corporate Secretary | Common Stock | โ | Oct 1, 2026 | Sale | 16,605 | $90.35 | $1,500,261.75 | 14,773 | Direct | โ | View Details | |
Chief Legal Officer and Corporate Secretary | Common Stock | โ | Oct 1, 2026 | Sale | 7,228 | $91.35 | $660,277.80 | 7,545 | Direct | โ | View Details | |
Chief Legal Officer and Corporate Secretary | Common Stock | โ | Oct 1, 2026 | Sale | 2,100 | $92.70 | $194,670.00 | 5,445 | Direct | โ | View Details | |
Chief Legal Officer and Corporate Secretary | Common Stock | โ | Oct 1, 2026 | Sale | 2,600 | $93.46 | $242,996.00 | 2,845 | Direct | โ | View Details | |
Chief Legal Officer and Corporate Secretary | Stock Option (Right to Buy) | Derivative | Oct 1, 2026 | Exercise/Conversion | 28,933 | $0.00 | $0.00 | 482,478 | Direct | โ | View Details |